3Reddy UM,Laughon SK,Sun L,et al.Prepregnancy risk factors for antepartum stillbirth in the United States[J].Obstet Gynecol,2010,116(5):1119-1126.
4Ferrer RL,Sibai BM,Murlow CD,et al.Management of mild chronic hypertension during pregnancy:A review[J].Obstet Gynecol,2000,96(5 Pt 2):849-860.
5Cockburn J,Moar VA,Ounsted M,et al.Final report of study on hypertension during pregnancy:the effects of specific treatment on the growth and development of the children[J].Lancet,1982,1(8273):647-649.
6Mancia G,De Backer G,Dominiczak A.Guideline for the management of arterial hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)[J].Eur Heart J,2007,28(12):1503-1504.
8Abalos E,Duley L,Steyn DW,et al.Antihypertensive drug therapy for mild to moderate hypertension during pregnancy[DB].Cochrane Database Syst Rev,2007,24(1):CD002252.
9Tabacova S,Kimmel CA,Wall K,et al.Atenolol development toxicity:animal-to-human comparisons[J].Birth Defects Res A Clin Mol Teratol,2003,67(3):181-192.
10The Society of Obstetricians and Gynaecologists of Canada.Diagnosis,evaluation,and management of the hypertensive disorders of pregnancy[J].J Obstet Gynaecol Can,2008,30(3 Suppl):S1-S48.
二级参考文献7
1WHO. Intemational statistical classification of diseases and related health problem (ICD-10). 10^th rev. Geneva, Switzerland: WHO, 1993.
2Hill K, Thomas K, AbouZahr C, et al. Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lacet, 2007,370 (9595) : 1311-1319.
3WHO, UNICEF, UNFPA. Maternal mortality in 2000: estimates developed by WHO, UNICEF, UNFPA. Geneva: WHO, 2004.
4Betran AP, Wojdyla D, Posner SF, et al. National estimates for maternal mortality: an analysis based on the WHO systematic review of maternal mortality and morbidity. BMC Public Health, 2005,5: 131-142.
